[Pharmacological studies of a new analgesic, 1-(m-methoxyphenyl)-2-dimethylaminomethylcyclohexanol(1) hydrochloride (K-315). 1. Analgesic effects and general pharmacological action].
D000200:Action Potentials / Q000187:drug effects; D000438:Alcohols / Q000494:pharmacology*; D000632:Aminopyrine / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D000996:Antitussive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002415:Cats; D003510:Cyclohexanes / Q000494:pharmacology*; D003511:Cyclohexanols / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005725:Ganglia, Autonomic / Q000187:drug effects; D006168:Guinea Pigs; D007422:Intestines / Q000187:drug effects; D008297:Male; D008614:Meperidine / Q000494:pharmacology; D008744:Methylamines / Q000494:pharmacology; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010423:Pentazocine / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects
D000438:Alcohols; D000700:Analgesics; D000996:Antitussive Agents; D003510:Cyclohexanes; D003511:Cyclohexanols; D008744:Methylamines; D000632:Aminopyrine; D009020:Morphine; D008614:Meperidine; D010423:Pentazocine